SOPHIA Trial in HER+ Metastatic Breast Cancer

obr has 860 videos Subscribe Here

Description: Debu Tripathy, MD, Professor and Chair, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center explains the results of the SOPHIA trial, a phase III study of chemotherapy plus margetuximab or trastuzumab in HER+ metastatic breast cancer.
Shared By : obr
Posted on : 07/02/19
Added : 2 months ago
Category : Breast Cancer